Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 04:00PM ET
30.40
Dollar change
-0.18
Percentage change
-0.60
%
CategoryGlobal or ExUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsU.S. Return% 1Y7.12% Shs Outstand Perf Week-1.12%
SponsorFranklin Templeton ETF Type Tagsequity Return% 3Y- Total Holdings37 Perf Month-2.13%
Fund Family Bond Type Tagshealthcare Return% 5Y- AUM5.36M Perf Quarter-5.73%
Index- Average Maturity Tagsbiotechnology Return% 10Y NAV% Perf Half Y2.69%
Index Weighting Commodity Type Tagsinnovation Return% SI NAV/sh Perf Year10.80%
Active/Passive Quant Type Tags- Flows% 1M0.00% 52W Range27.63 - 33.23 Perf YTD4.45%
Dividend TTM0.21 (0.70%) ESG Type Tags- Flows% 3M0.00% 52W High-8.52% Beta0.98
Dividend Ex-DateDec 05, 2024 Dividend Type Sector/Theme Flows% YTD-34.96% 52W Low10.01% ATR (14)0.25
Expense0.70% Structure Type Region Flows% 1Y RSI (14)40.90 Volatility0.15% 0.10%
Option/ShortNo / No Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.52 Prev Close30.58
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume0.18K Price30.40
SMA20-0.67% SMA50-3.66% SMA200-1.21% Trades Volume96 Change-0.60%
Putnam Biorevolution ETF seeks long term capital appreciation. The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on "biology revolution" companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors. The fund is non-diversified.